What If Medicines Could Decide When to Work?

In this enlightening conversation, Kaushik Trivedi speaks with Sophia Lugo, CEO of Radar Therapeutics, about the transformative potential of programmable genetic medicines. They explore the limitations of current mRNA therapies, the importance of precision over power in medicine, and the ethical implications of innovation in healthcare. Sophia shares her personal journey, the challenges of building a biotech company, and the need for public trust in genetic medicine. This discussion highlights the future of medicine as not just more advanced, but more intentional and responsible.The biggest problem in modern medicine may be the bluntness of drugs. Medicines should not only act but also decide when and where to work. Sophia Lugo is driven by a desire for justice and equal access to technology. Personal responsibility and hard work are key to success. mRNA therapies have not yet achieved therapeutic approval, only vaccines. Precision in medicine is becoming more important than raw power. Programmable medicines could fundamentally change drug development. Public trust in genetic medicine involves emotional and ethical considerations. The human aspect of building a biotech company is often more challenging than the science. The future of medicine will be more intentional, focusing on the impact on humanity.00:00 The Evolution of Medicine: From Power to Precision11:11 The Limitations of Current Genetic TherapiesIf you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore.Connect with Kaushik Trivedi:Instagram: https://www.instagram.com/drugdiaries_/